Literature DB >> 19135945

Possible association between obesity and posttransplantation complications including infectious diseases and acute graft-versus-host disease.

Shigeo Fuji1, Sung-Won Kim, Ken-ichi Yoshimura, Hideki Akiyama, Shin-ichiro Okamoto, Hiroshi Sao, Junko Takita, Naoki Kobayashi, Shin-ichiro Mori.   

Abstract

Both obesity and malnutrition are considered risk factors for complications after bone marrow transplantation (BMT). To elucidate the impact of pretransplantation body mass index (BMI) on clinical outcome, we performed a retrospective cohort study with registration data from the Japan Marrow Donor Program (JMDP). Between January 1998 and December 2005, a total of 3935 patients received unrelated BMT through the JMDP; of these, 3827 patients for whom pretransplantation height and weight data were available were included in the study. Patients were stratified according to pretransplantation BMI values (low BMI: BMI < 18 kg/m(2), n = 295; normal BMI: 18 < or = BMI < 25 kg/m(2), n = 2906; overweight: 25 < or = BMI <30 kg/m(2), n = 565; obese: 30 kg/m(2) < or = BMI, n = 61). In a univariate analysis, pretransplantation BMI was associated with a significantly greater risk of grade II-IV acute graft-versus-host disease (GVHD; P = .03). Multivariate analysis showed that pretransplantation BMI tended to be associated with an increased risk of grade II-IV acute GVHD (P = .07). Obesity was associated with an increased risk of infection compared with normal BMI (odds ratio = 1.9; 95% confidence interval = 1.1 to 3.2; P = .02). Our findings demonstrate a correlation between pretransplantation BMI and posttransplantation complications. Although BMI depends strongly on multiple factors, the effect of obesity on clinical outcome should be evaluated in a prospective study.

Entities:  

Mesh:

Year:  2009        PMID: 19135945     DOI: 10.1016/j.bbmt.2008.10.029

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  20 in total

1.  The impact of pre-transplant body weight on short- and long-term outcomes after allogeneic hematopoietic cell transplantation in adults using different weight classification tools.

Authors:  P Urbain; G Ihorst; J Finke; H Bertz
Journal:  Bone Marrow Transplant       Date:  2015-10-05       Impact factor: 5.483

2.  Impact of being overweight on outcomes of hematopoietic SCT: a meta-analysis.

Authors:  M Nakao; D Chihara; A Niimi; R Ueda; H Tanaka; Y Morishima; K Matsuo
Journal:  Bone Marrow Transplant       Date:  2013-08-19       Impact factor: 5.483

3.  Trajectories of Fasting Blood Glucose in Autologous Hematopoietic Cell Transplantation.

Authors:  Marilyn J Hammer; Steven M Paul; Amir Steinberg; Patricia Eckardt; Margaret Barton-Burke; Christine Miaskowski
Journal:  Cancer Nurs       Date:  2019 Jul/Aug       Impact factor: 2.592

4.  Immunological complications of obesity.

Authors:  Thirumala-Devi Kanneganti; Vishwa Deep Dixit
Journal:  Nat Immunol       Date:  2012-07-19       Impact factor: 25.606

5.  Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia.

Authors:  Collin C Barker; Manza-A Agovi; Brent Logan; Hillard M Lazarus; Karen K Ballen; Vikas Gupta; Gregory A Hale; Haydar Frangoul; Vincent Ho; J Douglas Rizzo; Marcelo C Pasquini
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-14       Impact factor: 5.742

6.  Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT.

Authors:  S Fuji; K Takano; T Mori; T Eto; S Taniguchi; K Ohashi; H Sakamaki; Y Morishima; K Kato; K Miyamura; R Suzuki; T Fukuda
Journal:  Bone Marrow Transplant       Date:  2014-08-11       Impact factor: 5.483

7.  Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance.

Authors:  Hyunwon Yang; Yun-Hee Youm; Bolormaa Vandanmagsar; Anthony Ravussin; Jeffrey M Gimble; Frank Greenway; Jacqueline M Stephens; Randall L Mynatt; Vishwa Deep Dixit
Journal:  J Immunol       Date:  2010-06-25       Impact factor: 5.422

8.  Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.

Authors:  Richard Aplenc; Mei-Jie Zhang; Lillian Sung; Xiaochun Zhu; Vincent T Ho; Kenneth Cooke; Christopher Dvorak; Gregory Hale; Luis M Isola; Hillard M Lazarus; Philip L McCarthy; Richard Olsson; Michael Pulsipher; Marcelo C Pasquini; Nancy Bunin
Journal:  Blood       Date:  2014-04-07       Impact factor: 22.113

9.  Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Authors:  Noga Shem-Tov; Myriam Labopin; Leila Moukhtari; Fabio Ciceri; Jordi Esteve; Sebastian Giebel; Norbert-Claude Gorin; Christopher Schmid; Avichai Shimoni; Arnon Nagler; Mohamad Mohty
Journal:  Oncologist       Date:  2014-12-05

10.  Severe hyperglycemia immediately after allogeneic hematopoietic stem-cell transplantation is predictive of acute graft-versus-host disease.

Authors:  Efrem Gebremedhin; Carolyn E Behrendt; Ryotaro Nakamura; Pablo Parker; Behrouz Salehian
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.